CHRS Latest Press Releases

-- September 23, 2026 --

Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets Globe Newswire 9:30 AM

-- August 31, 2026 --

Coherus to Participate in Upcoming Investor Conferences Globe Newswire 9:30 AM

-- August 17, 2026 --

Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights Globe Newswire 5:33 PM

-- August 5, 2026 --

Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:28 PM

-- July 22, 2026 --

Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026 Globe Newswire 1:36 PM

-- June 23, 2026 --

Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI (toripalimab-tpzi) Globe Newswire 2:00 PM

-- May 11, 2026 --

Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software